APA

Feagan B. G., Rubin D. T., Danese S., Vermeire S., Abhyankar B., Sankoh S., James A. & Smyth M. (20170906). Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Chicago

Feagan Brian G, Rubin David T, Danese Silvio, Vermeire Severine, Abhyankar Brihad, Sankoh Serap, James Alexandra and Smyth Michael. 20170906. Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Harvard

Feagan B. G., Rubin D. T., Danese S., Vermeire S., Abhyankar B., Sankoh S., James A. and Smyth M. (20170906). Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

MLA

Feagan Brian G, Rubin David T, Danese Silvio, Vermeire Severine, Abhyankar Brihad, Sankoh Serap, James Alexandra and Smyth Michael. Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists. : Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20170906.